Without A Prescription |
| ||
|
BONMAX Evista |
|
| ||
Home » Prescription Drugs 3 » BONMAX Evista Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures.Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause.This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen receptor modulator or SERM) in some parts of the body. Raloxifene helps to preserve bone mass but it does not affect the breast and uterus like estrogen or relieve symptoms of menopause such as hot flashes.This medication is not recommended for use in women before menopause. It should not be used in children.This medication should not be used to prevent heart disease.How to use Raloxifene OralTake this medication by mouth usually once a day with or without food or as directed by your doctor. Use this medication regularly to get the most benefit from it. Remember to use it at the same time each day.Be sure to include adequate amounts of calcium and vitamin D in your diet. Consult your doctor or pharmacist to see if you need to take calcium/vitamin D supplements. Buy BONMAX Evista and other Prescription Drugs 3 products online at Medstore. 330
About BONMAX Evista: Product Type: Prescription Drugs 3 BONMAX ( Evista Generic Raloxifene ) BONMAX (Evista Generic Raloxifene) Evista Generic Raloxifene 60mg 28 (4 x 7) Evista Generic Raloxifene BONMAX
View more Prescription Drugs 3 Without A Prescription: Education on antibiotic prescribing in Quebec worked. Guidelines for Quebec doctors on proper antibiotic use led to a decline in these prescriptions in the province, while prescribing rose in other provinces, a new study suggests. The guidelines were published and disseminated to Quebec doctors and pharmacists in January 2005 due to worries about the overuse of antibiotics and partly as a response to an outbreak of Clostridium difficile infections. Antibiotic consumption per capita was already 23.3 per cent higher in Canada generally than in Quebec in 2004, the study showed. But in the year that followed publication of the guidelines, the number of outpatient antibiotic prescriptions in Quebec decreased 4.2 per cent, the study said, while increasing 6.5 per cent in other Canadian provinces. The trend persisted three years later.
| ||
